Provided by Tiger Trade Technology Pte. Ltd.

Arvinas Holding Company LLC

9.45
+0.16501.78%
Volume:217.31K
Turnover:2.05M
Market Cap:617.57M
PE:70.65
High:9.59
Open:9.28
Low:9.27
Close:9.28
52wk High:14.51
52wk Low:6.97
Shares:65.39M
Float Shares:56.67M
Volume Ratio:0.47
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1337
EPS(LYR):-1.1400
ROE:1.59%
ROA:-1.01%
PB:1.10
PE(LYR):-8.29

Loading ...

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Arvinas Holding Company (ARVN)

TIPRANKS
·
May 22

Analysts Conflicted on These Healthcare Names: Arvinas Holding Company (ARVN) and SCHOTT Pharma AG & Co. KGaA (Milan: IT:1SXP)

TIPRANKS
·
May 16

BofA Securities Raises Price Target on Arvinas to $16 From $14

MT Newswires Live
·
May 14

U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

Reuters
·
May 14

Arvinas Inc : Leerink Partners Cuts Target Price to $9 From $18

THOMSON REUTERS
·
May 14

Arvinas price target raised to $16 from $14 at BofA

TIPRANKS
·
May 14

These Analysts Increase Their Forecasts On Arvinas After Q1 Results

Benzinga Earnings
·
May 14

Arvinas Is Maintained at Buy by BTIG

Dow Jones
·
May 13

Arvinas Holding Company (ARVN) Receives a Buy from Wells Fargo

TIPRANKS
·
May 13

Arvinas price target raised to $20 from $18 at Barclays

TIPRANKS
·
May 13

U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic

Reuters
·
May 13

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Sensus Healthcare (SRTS)

TIPRANKS
·
May 13

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

TIPRANKS
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, Illumina

Reuters
·
May 13

Arvinas Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

BUZZ-U.S. STOCKS ON THE MOVE-Under Armour, C3 AI, Rigel Pharma

Reuters
·
May 12

Arvinas Grants Rigel Global Rights to VEPPANU Therapy

TIPRANKS
·
May 12

Arvinas publishes corporate presentation on PROTAC protein degraders in cancer, neurodegenerative diseases

Reuters
·
May 12

Arvinas, Pfizer Tap Rigel Pharmaceuticals to Bring Veppanu to Market

Dow Jones
·
May 12

Arvinas Q1 sales miss estimates on lower collaboration revenue from Pfizer

Reuters
·
May 12